Yili Chuanning Biotechnology Co.,Ltd.

Informe acción SZSE:301301

Capitalización de mercado: CN¥28.5b

Yili Chuanning BiotechnologyLtd Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Xuheng Deng

Chief Executive Officer (CEO)

CN¥1.4m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

No hay actualizaciones

Recent updates

These 4 Measures Indicate That Yili Chuanning BiotechnologyLtd (SZSE:301301) Is Using Debt Safely

Oct 11
These 4 Measures Indicate That Yili Chuanning BiotechnologyLtd (SZSE:301301) Is Using Debt Safely

If EPS Growth Is Important To You, Yili Chuanning BiotechnologyLtd (SZSE:301301) Presents An Opportunity

Jul 23
If EPS Growth Is Important To You, Yili Chuanning BiotechnologyLtd (SZSE:301301) Presents An Opportunity

We Think Yili Chuanning BiotechnologyLtd (SZSE:301301) Can Manage Its Debt With Ease

May 31
We Think Yili Chuanning BiotechnologyLtd (SZSE:301301) Can Manage Its Debt With Ease

Yili Chuanning BiotechnologyLtd (SZSE:301301) Could Easily Take On More Debt

Feb 26
Yili Chuanning BiotechnologyLtd (SZSE:301301) Could Easily Take On More Debt

CEO

Xuheng Deng (37 yo)

no data

Permanencia

CN¥1,389,100

Compensación

Mr. Xuheng Deng serves as GM & Director of Yili Chuanning Biotechnology Co.,Ltd.